Kintegral Advisory LLC trimmed its holdings in shares of The Clorox Company (NYSE:CLX – Free Report) by 4.5% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 15,114 shares of the company’s stock after selling 704 shares during the quarter. Kintegral Advisory LLC’s holdings in Clorox were worth $2,455,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the business. Brooklyn Investment Group grew its stake in shares of Clorox by 163.8% in the fourth quarter. Brooklyn Investment Group now owns 153 shares of the company’s stock worth $25,000 after purchasing an additional 95 shares during the last quarter. Prospera Private Wealth LLC bought a new stake in shares of Clorox in the 3rd quarter valued at about $27,000. Continuum Advisory LLC increased its stake in shares of Clorox by 300.0% in the third quarter. Continuum Advisory LLC now owns 184 shares of the company’s stock valued at $30,000 after buying an additional 138 shares during the period. Asset Planning Inc bought a new position in shares of Clorox during the fourth quarter worth about $32,000. Finally, Catalyst Capital Advisors LLC acquired a new position in shares of Clorox in the third quarter worth approximately $54,000. 78.53% of the stock is currently owned by institutional investors and hedge funds.
Analysts Set New Price Targets
A number of analysts have weighed in on the stock. TD Cowen raised shares of Clorox from a “sell” rating to a “hold” rating and increased their target price for the company from $155.00 to $170.00 in a research report on Wednesday, November 6th. DA Davidson decreased their price objective on shares of Clorox from $171.00 to $169.00 and set a “neutral” rating for the company in a research report on Wednesday, February 5th. JPMorgan Chase & Co. boosted their price objective on Clorox from $171.00 to $173.00 and gave the company a “neutral” rating in a research note on Tuesday, February 4th. Royal Bank of Canada reaffirmed a “sector perform” rating and set a $150.00 target price on shares of Clorox in a research note on Thursday, January 30th. Finally, StockNews.com lowered Clorox from a “buy” rating to a “hold” rating in a research note on Sunday, January 5th. Four analysts have rated the stock with a sell rating, eleven have assigned a hold rating and one has assigned a buy rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus target price of $158.21.
Clorox Stock Up 2.8 %
Clorox stock opened at $157.41 on Friday. The firm has a market capitalization of $19.39 billion, a price-to-earnings ratio of 43.01, a price-to-earnings-growth ratio of 2.58 and a beta of 0.42. The firm’s fifty day moving average price is $157.87 and its two-hundred day moving average price is $159.63. The Clorox Company has a 1-year low of $127.60 and a 1-year high of $171.37. The company has a current ratio of 0.94, a quick ratio of 0.60 and a debt-to-equity ratio of 20.52.
Clorox (NYSE:CLX – Get Free Report) last announced its quarterly earnings results on Monday, February 3rd. The company reported $1.55 earnings per share for the quarter, beating the consensus estimate of $1.39 by $0.16. Clorox had a net margin of 6.38% and a return on equity of 316.87%. During the same period in the previous year, the business posted $2.16 EPS. On average, equities research analysts predict that The Clorox Company will post 7.15 earnings per share for the current fiscal year.
About Clorox
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
Recommended Stories
- Five stocks we like better than Clorox
- Best Aerospace Stocks Investing
- 3 Stocks Poised to Thrive as NVIDIA Dominates the AI Boom
- What Makes a Stock a Good Dividend Stock?
- MercadoLibre: High-Growth EM Stock With 100% Upside Potential
- How to Use the MarketBeat Dividend Calculator
- As the Magnificent 7 Stalls, These 3 Stocks Are Gaining Momentum
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.